152 related articles for article (PubMed ID: 11853200)
1. A new method for determining patient payments for outpatient drugs.
Goldman DP; Lakdawalla D
Am J Manag Care; 2002 Feb; 8(2):125, 128, 130. PubMed ID: 11853200
[No Abstract] [Full Text] [Related]
2. The managed care prescription benefit. Challenged by shifting care and shifting costs.
Bender J
AAPPO J; 1991; 1(4):11-8. PubMed ID: 10149632
[No Abstract] [Full Text] [Related]
3. A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost.
Fendrick AM; Smith DG; Chernew ME; Shah SN
Am J Manag Care; 2001 Sep; 7(9):861-7. PubMed ID: 11570020
[TBL] [Abstract][Full Text] [Related]
4. Escalating need for comparative analysis of drugs within a therapeutic class.
Giaquinta D
Manag Care Interface; 2003 Oct; 16(10):32-4. PubMed ID: 14606258
[No Abstract] [Full Text] [Related]
5. Mass customization--the next generation of pharmacy management.
Chao S
Am J Manag Care; 2003 Sep; Suppl Decison Maker News():5-7. PubMed ID: 14567452
[No Abstract] [Full Text] [Related]
6. Pharmaceutical formularies: the right formula for cost and utilization?
Austin B
Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
[No Abstract] [Full Text] [Related]
7. Cap for injectables not for the faint of heart.
Capitation Rates Data; 2003 Jul; 8(7):79-81. PubMed ID: 12908211
[No Abstract] [Full Text] [Related]
8. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
Liu SZ; Romeis JC
Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
[TBL] [Abstract][Full Text] [Related]
9. Managed care cost containment involving prescription drugs. American Medical Association, Council on Ethical and Judicial Affairs.
Food Drug Law J; 1998; 53(1):25-34. PubMed ID: 11795334
[No Abstract] [Full Text] [Related]
10. Over-the-counter drugs as a new managed care benefit.
Scheur BS; Aaron RM
Med Interface; 1997 Feb; 10(2):88-94. PubMed ID: 10164797
[TBL] [Abstract][Full Text] [Related]
11. Integrating new technology without going broke.
Starr C
Bus Health; 2002; 20(1):29-34. PubMed ID: 12534112
[No Abstract] [Full Text] [Related]
12. Stats & facts. More consumer cost sharing in pharmacy benefit.
Manag Care Interface; 2002 Apr; 15(4):34-5. PubMed ID: 11979701
[No Abstract] [Full Text] [Related]
13. Managed care outlook. Employers struggle to preserve pharmacy benefit.
Manag Care; 2002 Jan; 11(1):56. PubMed ID: 11828877
[No Abstract] [Full Text] [Related]
14. Use of randomized controlled trials in organizational decision making: a cost-minimization approach.
Cher DJ; Maclure M
Am J Manag Care; 2000 Aug; 6(8):894-904. PubMed ID: 11186501
[No Abstract] [Full Text] [Related]
15. The effect of managed care on community pharmacy reimbursement.
Navarro RP
Manag Care Interface; 1999 Feb; 12(2):65-6, 68. PubMed ID: 10346188
[No Abstract] [Full Text] [Related]
16. Using patient classification systems to identify ambulatory care costs.
Karpiel MS
Healthc Financ Manage; 1994 Nov; 48(11):30-4, 36-7. PubMed ID: 10146093
[TBL] [Abstract][Full Text] [Related]
17. Financial incentives and drug spending in managed care.
Hillman AL; Pauly MV; Escarce JJ; Ripley K; Gaynor M; Clouse J; Ross R
LDI Issue Brief; 1999 May; 4(1):1-4. PubMed ID: 12523336
[TBL] [Abstract][Full Text] [Related]
18. Plans continue to raise copayments.
Manag Care; 2005 Sep; 14(9):59. PubMed ID: 16238260
[No Abstract] [Full Text] [Related]
19. Rebates and other drug-cost issues.
Penna P
Manag Care Interface; 2003 May; 16(5):39-40. PubMed ID: 12789863
[No Abstract] [Full Text] [Related]
20. Cost not the primary factor driving drug coverage.
Capitation Rates Data; 2000 May; 5(5):51-3. PubMed ID: 11066970
[No Abstract] [Full Text] [Related]
[Next] [New Search]